THE HEART LASER TM CO2 LASER SYSTEM FOR TRANSMYOCARDIAL REVASCULARIZATION

System, Laser, Transmyocardial Revascularization

FDA Premarket Approval P950015

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the heart laser co2 tmr system. This device is indicated for the treatment of patients with stable angina (canadian cardiovascular society class 3 or 4) refractory to medical treatment and secondary to objectively demonstarted coronary artery atherosclerosis not amenable to direct coronary revascularization.

DeviceTHE HEART LASER TM CO2 LASER SYSTEM FOR TRANSMYOCARDIAL REVASCULARIZATION
Classification NameSystem, Laser, Transmyocardial Revascularization
Generic NameSystem, Laser, Transmyocardial Revascularization
ApplicantLaser Engineering Heart Inc.
Date Received1995-04-18
Decision Date1998-08-20
Notice Date1999-08-17
PMAP950015
SupplementS
Product CodeMNO
Docket Number99M-2672
Advisory CommitteeCardiovascular
Expedited ReviewYes
Combination Product No
Applicant Address Laser Engineering Heart Inc. 475 Metroplex Drive, Suite 401 nashville, TN 37211
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P950015Original Filing
S012 2013-10-07 Normal 180 Day Track No User Fee
S011 2008-09-12 Normal 180 Day Track No User Fee
S010 2004-07-06 Normal 180 Day Track
S009
S008 2000-09-28 Normal 180 Day Track
S007 2000-09-12 Real-time Process
S006 1999-11-24 Special (immediate Track)
S005 1999-06-28 Normal 180 Day Track
S004
S003 1999-05-14 Normal 180 Day Track
S002 1999-03-29 Special (immediate Track)
S001 1998-09-21 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.